CANDEL THERAPEUTICS, INC. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
CANDEL THERAPEUTICS, INC. (CADL) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $121.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2025-03-13
- CANDEL THERAPEUTICS, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $121.00K.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|
| 2023-12-31 | $121.00K 10-K · filed 2025-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |